High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.3M
$5,262,483
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CAPR |
CAPRICOR THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2026-04-02 | $240,928 | S | Form 4 |
|
CAPR
S
CAPRICOR THERAPEUTICS, INC.
Sabar Karimah Es
• Director
10b5-1 Sell
2026-04-01
$1,667,225Large
|
||||||
| CAPR |
CAPRICOR THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2026-04-01 | $1,667,225Large | S | Form 4 |
|
CAPR
S
CAPRICOR THERAPEUTICS, INC.
Bergmann Anthony
• CFO
10b5-1 SellΔOwn -75.2%
2026-03-31
$753,152
|
||||||
| CAPR |
CAPRICOR THERAPEUTICS, INC.
|
CFO
10b5-1 SellΔOwn -75.2%
|
2026-03-31 | $753,152 | S | Form 4 |
|
CAPR
S
CAPRICOR THERAPEUTICS, INC.
Krasney Karen
• Officer • EVP, GENERAL COUNSEL
10b5-1 SellΔOwn -45.0%
2026-03-31
$752,935
|
||||||
| CAPR |
CAPRICOR THERAPEUTICS, INC.
|
Officer • EVP, GENERAL COUNSEL
10b5-1 SellΔOwn -45.0%
|
2026-03-31 | $752,935 | S | Form 4 |
|
CAPR
S
CAPRICOR THERAPEUTICS, INC.
Sabar Karimah Es
• Director
10b5-1 Sell
2026-03-31
$1,848,243Large
|
||||||
| CAPR |
CAPRICOR THERAPEUTICS, INC.
|
Director
10b5-1 Sell
|
2026-03-31 | $1,848,243Large | S | Form 4 |